Company intelligence / Profile preview

Reignwood Group

Hong Kong

Ownership: Private
Employees: ~28
Development stage: Other

Overview

Reignwood Group is a diversified multinational conglomerate with investments across various sectors including fast-moving consumer goods (FMCG), green ecology, health industry, culture and tourism, and strategic investments. They are notably an investor in the biotech firm Humacyte, highlighting their involvement in the health sector.

Industry: Investors

Partnerships

Humacyte (investor)

Beyond the preview

Go deeper on Reignwood Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reignwood Group.

Explore the full profile